Creating Value by Overcoming Treatment Barriers View previous quarters - Today Latest News View all press releases 07.07.26 Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism Read More 05.13.26 Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Read More 05.12.26 Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree Read More Events View all events Upcoming Events There are no scheduled events at this time. Past Events 05.14.26 8:00 AM EDT Q1 2026 Aquestive Therapeutics, Inc. Earnings Conference Call 03.10.26 8:25 AM EDT Citizens Life Sciences Conference Presentations View all presentations Corporate Presentation – February 2026 Anaphylm™ (dibutepinephrine) Sublingual Film Complete Response Letter Supplemental Material 1.1 MB Anaphylm Pre-NDA Meeting Supplemental Material 525.4 KB
07.07.26 Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism Read More
05.13.26 Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Read More
